Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ELTROMBOPAG | 50MG | TABLET | Resolved | 2024-03-08 | 2024-04-05 | 221699 |
| APO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2025-04-04 | 2025-05-02 | 254156 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2018-03-05 | 2018-03-20 | 41868 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-09-04 | 2019-09-06 | 92974 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-07-12 | 2019-08-17 | 89158 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2017-09-27 | 2017-10-02 | 23663 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-04-04 | 2019-05-21 | 80530 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2021-04-09 | 2021-06-07 | 137241 |
| APO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2023-04-14 | 2023-05-19 | 189650 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2024-10-10 | 2024-11-08 | 239822 |
| APO-ENALAPRIL | 20MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213562 |
| APO-ENALAPRIL TAB 10MG | 10MG | TABLET | Resolved | 2017-11-01 | 2018-01-03 | 27703 |
| APO-ENALAPRIL TAB 10MG | 10MG | TABLET | Resolved | 2022-06-17 | 2022-06-30 | 162913 |
| APO-ENALAPRIL TAB 10MG | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37949 |
| APO-ENALAPRIL TAB 2.5MG | 2.5MG | TABLET | Resolved | 2019-08-07 | 2019-12-19 | 91078 |
| APO-ENALAPRIL TAB 2.5MG | 2.5MG | TABLET | Resolved | 2020-11-26 | 2021-03-09 | 128942 |
| APO-ENALAPRIL TAB 20MG | 20MG | TABLET | Resolved | 2021-08-27 | 2022-07-11 | 144672 |
| APO-ENALAPRIL TAB 20MG | 20MG | TABLET | Resolved | 2017-11-01 | 2018-04-07 | 27707 |
| APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Resolved | 2020-09-09 | 2021-03-09 | 123932 |
| APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37953 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |